Sickle Cell Anemia: Stem Cell Gene Therapy – Donald Kohn

Posted: August 2, 2011 at 10:48 am



(Part 1 of 2) CIRM has funded a $9 million disease team to develop a more effective and safer bone marrow transplant to treat sickle cell disease. The team is led by Dr. Donald Kohn, director of the Human Gene Medicine Program at UCLA, a scientist with the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and a professor of microbiology and pediatrics.

Original post:
Sickle Cell Anemia: Stem Cell Gene Therapy - Donald Kohn

Related Post

Comments are closed.

Archives